Association of Long‐term Change in Waist Circumference With Insulin Resistance

[1]  K. Flegal,et al.  Prevalence and trends in obesity among US adults, 1999-2008. , 2010, JAMA.

[2]  D. Jacobs,et al.  Relationship between serum concentrations of persistent organic pollutants and the prevalence of metabolic syndrome among non-diabetic adults: results from the National Health and Nutrition Examination Survey 1999–2002 , 2007, Diabetologia.

[3]  D. Jacobs,et al.  Abdominal obesity and coronary artery calcification in young adults: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. , 2007, The American journal of clinical nutrition.

[4]  S. Gravas Epidemiologic trends indicate the prevalence of obesity will rise globally. , 2007, European urology.

[5]  D. Jacobs,et al.  Association Between Serum Concentrations of Persistent Organic Pollutants and Insulin Resistance Among Nondiabetic Adults , 2007, Diabetes Care.

[6]  Liviu Klein,et al.  Consistently Stable or Decreased Body Mass Index in Young Adulthood and Longitudinal Changes in Metabolic Syndrome Components: The Coronary Artery Risk Development in Young Adults Study , 2007, Circulation.

[7]  D. Jacobs,et al.  Could low-level background exposure to persistent organic pollutants contribute to the social burden of type 2 diabetes? , 2006, Journal of Epidemiology and Community Health.

[8]  D. Jacobs,et al.  A Strong Dose-Response Relation Between Serum Concentrations of Persistent Organic Pollutants and Diabetes , 2006, Diabetes Care.

[9]  Shinji Kihara,et al.  Adiponectin: a key adipocytokine in metabolic syndrome. , 2006, Clinical science.

[10]  M. Schulze,et al.  Body mass index history and risk of type 2 diabetes: results from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. , 2006, The American journal of clinical nutrition.

[11]  R. Paffenbarger,et al.  Weight change and risk of developing type 2 diabetes. , 2005, Obesity research.

[12]  S. Wannamethee,et al.  Overweight and obesity and weight change in middle aged men: impact on cardiovascular disease and diabetes , 2005, Journal of Epidemiology and Community Health.

[13]  J. Connell,et al.  The role of insulin and the adipocytokines in regulation of vascular endothelial function. , 2004, Clinical science.

[14]  Marjolein Visser,et al.  Re: "Changes in body weight and body fat distribution as risk factors for clinical diabetes in US men". , 2004, American journal of epidemiology.

[15]  R. Turner,et al.  Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.

[16]  Donna Spiegelman,et al.  Changes in body weight and body fat distribution as risk factors for clinical diabetes in US men. , 2004, American journal of epidemiology.

[17]  H. Lebovitz The relationship of obesity to the metabolic syndrome. , 2003, International journal of clinical practice. Supplement.

[18]  K. Flegal,et al.  Prevalence and trends in obesity among US adults, 1999-2000. , 2002, JAMA.

[19]  K. Frayn,et al.  Adipose tissue as a buffer for daily lipid flux , 2002, Diabetologia.

[20]  S. O’Rahilly,et al.  Metabolism: Partial leptin deficiency and human adiposity , 2001, Nature.

[21]  Bruce M. Spiegelman,et al.  Obesity and the Regulation of Energy Balance , 2001, Cell.

[22]  B. Wajchenberg Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. , 2000, Endocrine reviews.

[23]  A. Tremblay,et al.  Body weight loss increases plasma and adipose tissue concentrations of potentially toxic pollutants in obese individuals , 2000, International Journal of Obesity.

[24]  J. Flier,et al.  Obesity and insulin resistance. , 2000, The Journal of clinical investigation.

[25]  J. Halter,et al.  Relation of weight gain and weight loss on subsequent diabetes risk in overweight adults , 2000, Journal of epidemiology and community health.

[26]  S. O’Rahilly,et al.  The perils of portliness: causes and consequences of visceral adiposity. , 2000, Diabetes.

[27]  B. Fisher Most unwanted. , 1999, Environmental health perspectives.

[28]  J. Halaas,et al.  Leptin and the regulation of body weight in mammals , 1998, Nature.

[29]  A. Greenberg,et al.  Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1998 by The Endocrine Society Omental and Subcutaneous Adipose Tissues of Obese Subjects Release Interleukin-6: Depot Difference and Regulation by Glucocorticoid* , 1997 .

[30]  K. Uysal,et al.  Protection from obesity-induced insulin resistance in mice lacking TNF-α function , 1997, Nature.

[31]  D. Williamson,et al.  Weight change and diabetes incidence: findings from a national cohort of US adults. , 1997, American journal of epidemiology.

[32]  K. Uysal,et al.  Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. , 1997, Nature.

[33]  S. Haffner,et al.  Decreased Insulin Secretion and Increased Insulin Resistance Are Independently Related to the 7-Year Risk of NIDDM in Mexican-Americans , 1995, Diabetes.

[34]  G. Colditz,et al.  Weight Gain as a Risk Factor for Clinical Diabetes Mellitus in Women , 1995, Annals of Internal Medicine.

[35]  K. Narayan,et al.  Rate of Weight Gain, Weight Fluctuation, and Incidence of NIDDM , 1995, Diabetes.

[36]  E. Ravussin,et al.  Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians. , 1993, The New England journal of medicine.

[37]  B. Spiegelman,et al.  Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. , 1993, Science.

[38]  R. N. Bergman,et al.  Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study , 1992, The Lancet.

[39]  H. Lithell,et al.  Risk factors for developing non-insulin dependent diabetes: a 10 year follow up of men in Uppsala. , 1991, BMJ.

[40]  A. Fontbonne,et al.  Risk Factors for NIDDM in White Population: Paris Prospective Study , 1991, Diabetes.